JD.com's medical products spinoff has gone public in Hong Kong's largest initial public offering this year, valuing it at close to $29bn.
China-headquartered e-commerce group JD.com’s medical and healthcare-focused spinoff, JD Health, has floated on the Hong Kong Stock Exchange in a HK$27bn ($3.48bn) initial public offering, CNBC reported on Tuesday.
The offering involved JD Health issuing approximately 382 million shares priced at HK$70.58 each, at the top of the HK$62.80 to HK$70.58 range set by the company, valuing it at almost $29bn. It is the largest IPO in Hong Kong this year.
JD Health’s online platform sells prescription medication in addition…
